Effects of Berberine on Cardiometabolic Outcomes
Summary
NIH registers a randomized, placebo-controlled clinical trial (NCT07541898) on Berberine, an alkaloid compound, as a dietary intervention for cardiometabolic outcomes. The trial will enroll participants diagnosed with Cardiometabolic Syndrome and randomly assign them to receive Berberine or placebo. Conditions studied include cardiovascular disease and type 2 diabetes mellitus. Results will be reported to ClinicalTrials.gov.
What changed
ClinicalTrials.gov registered a new randomized, placebo-controlled trial (NCT07541898) investigating Berberine as a dietary intervention for cardiometabolic health. The study will enroll participants with Cardiometabolic Syndrome and randomize them to Berberine or placebo. No regulatory obligations or compliance requirements arise from this registration. Investigators conducting clinical trials involving Berberine or cardiometabolic interventions should register results on ClinicalTrials.gov per applicable federal requirements.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Effects of Berberine on Cardiometabolic Outcomes
N/A NCT07541898 Kind: NA Apr 21, 2026
Abstract
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Berberine may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.
Conditions: Cardiometabolic Syndrome
Interventions: Berberine, Placebo
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.